How much funding has Ataraxis AI raised?

Ataraxis AI has raised $24.4M in total funding, most recently a Series A round.

Who are Ataraxis AI's investors?

Ataraxis AI's investors include Obvious Ventures, Giant Ventures, AIX Ventures, Bertelsmann Investment, Founders Fund.

When was Ataraxis AI founded?

Ataraxis AI was founded in 2023.

Where is Ataraxis AI headquartered?

Ataraxis AI is headquartered in New York, New York, United States.

What industry is Ataraxis AI in?

Ataraxis AI operates in Artificial Intelligence, Biotech, Healthcare.

How many employees does Ataraxis AI have?

Ataraxis AI has 11-50 employees.

Ataraxis AI

Empowering physicians with advanced multi-modal tools to improve treatment selection and patient outcomes.

New York, United States · Founded 2023 · $24.4M raised

Artificial Intelligence

Biotech

Healthcare

Headquarters: New York, New York
Employees: 11–50
Founded: 2023
Business Model: B2B

Total Funding: $24.4M
Last Round: $20.4M Series AMar 2025
Rounds: 2

About

Ataraxis AI is an AI precision medicine company spun out of New York University in 2023, co-founded by Jan Witowski MD PhD and Krzysztof Geras PhD. The company develops advanced AI foundation models for oncology that learn tumor biology to predict cancer patient outcomes and guide treatment selection. Their flagship product, Ataraxis Breast, is an AI-native test for breast cancer that predicts recurrence risk, chemotherapy benefit, and neoadjuvant response using digital pathology. The company raised a $20.4 million Series A in 2025 and counts Yann LeCun among its advisors.

Summary

Ataraxis AI is an Artificial Intelligence company based in New York, United States, founded in 2023. It has raised $24.4M in total across 2 rounds, most recently a $20.4M Series A round in Mar 2025. Investors include Obvious Ventures, Giant Ventures and AIX Ventures.